OOIR: Observatory of International Research

Papers

(The H4-Index of World Allergy Organization Journal is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Cross-reactivity and sensitization profiles of cockroach and moth allergens provide new insights in cockroach-allergic patients	186
Quality and consistency of clinical practice guidelines on the prevention of food allergy and atopic dermatitis: Systematic review protocol	156
Omalizumab is effective in nasal polyposis with or without asthma, a real-life study	74
Dietary Fiber and Fatty Acids Affect Clinical Outcomes in Pediatric Obesity- Associated Asthma: Insights from the SOAP Study	72
Title page	59
Immune Dysregulation with Hyper-IgE–Like Phenotype and Recurrent Anaphylaxis in a 16-Year-Old Patient with 22q11.2 Microduplication Syndrome	56
Cutaneous Manifestations in Primary Immunodeficiency Diseases: A Comprehensive Review	53
Relationship between indoor inhalant allergen concentrations, serum IgE, and allergic diseases: A cross-sectional study from the NHANES 2005–2006 program	50
Penicillin allergy delabeling has a significant impact on subsequent antibiotic use in primary care	49
Monitoring disease activity of pollen allergies: What crowdsourced data are telling us	45
Corrigendum to “World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guidelines update – X – Breastfeeding a baby with cow's milk allergy” [World All	43
Hereditary angioedema diagnosis: Reflecting on the past, envisioning the future	42
The 2025 WAO Guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparities	42
Machine learning-based model for prediction of carbamazepine- and allopurinol-induced severe cutaneous adverse reactions in Vietnamese	40
Fructose biphosphate aldolase: A new cassava allergen	38
Hydrolyzed rice formula for dietary management of infants with cow's milk allergy	36
HMGB1 impairs nasal epithelial barrier via regulating autophagy in the pathogenesis of allergic rhinitis	36
Long-term effects of sublingual immunotherapy (SLIT) in preventing the development of asthma in allergic rhinitis: Revision of 15-year follow-up	35
From cockpit to community: Time to stop the use of first-generation H1-antihistamines	33
A preliminary investigation of the differences in immune responses in different strains of mice with localized allergic rhinitis tolerance models	33
Environmental contributions to the interactions of COVID-19 and asthma: A secondary publication and update	32
Clinical outcomes of allergen immunotherapy in children in Latin America: Treatment with polymerized allergen extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae	32
Prevalence and risk factors of de novo atopic diseases in pediatric liver transplant recipients: A retrospective cohort study	29
Epidemiology and molecular study of IgE mediated food allergy in South Tunisian children	29
Rethinking Inhaled Allergen Testing: A Cost-Effective and Evidence-Based Approach in Immunology Laboratories	28

Intranasal Monoclonal Antibody “Molecular Shield” as a Novel Preventive Strategy for Seasonal Allergic Rhinitis	27
Throat microbiota alterations in patients with hereditary angioedema	26
Association between circulating thyroperoxidase (TPO), anti-TPO IgE, anti-TPO IgG, and different clinical outcomes in chronic urticaria: A hypothesis-generating study	26
Epigenetic insights into food allergy: The potential role of DNA methylation in diagnosis and management	26
Assessing the national burden of allergic asthma by web-search data, pollen counts, and drug prescriptions in Germany and Sweden	26
Association between dietary zinc intake and asthma in overweight or obese children and adolescents: A cross-sectional analysis of NHANES	26
Have the prevalence of eczema symptoms increased in the Mexican pediatric population? Prevalence and associated factors according to Global Asthma Network Phase I	26